FDA approves Moderna COVID-19 vaccine for high-risk children | TechTarget

Retrieved on: 2025-07-11 20:22:34

Tags for this article:

Click the tags to see associated articles and topics

FDA approves Moderna COVID-19 vaccine for high-risk children | TechTarget. View article details on hiswai:

Excerpt

The FDA grants Moderna's Spikevax COVID-19 vaccine full approval for high-risk kids aged from 6 months to 11 years, ending its Emergency Use ...

Article found on: www.techtarget.com